top of page
Search

What Is Tirzepatide? Mounjaro®, Zepbound®, Benefits & Side Effects | DietApp.com

  • Writer: suport suport
    suport suport
  • 6 days ago
  • 3 min read

Updated: 4 days ago

What Is Tirzepatide? Mounjaro®, Zepbound®, Benefits, Side Effects & What to Expect

If you've recently been prescribed tirzepatide, you've probably noticed it goes by more than one name. Tirzepatide is the active ingredient in two FDA-approved medications — Mounjaro® and Zepbound® — and it works differently from other GLP-1 medications you may have heard of.

For medication-specific detail, see our Tirzepatide Guide, Mounjaro Guide, and Zepbound Guide.

What is tirzepatide? Medical infographic featuring Mounjaro® and Zepbound®, explaining weight loss benefits, blood sugar control, side effects, and what to expect during treatment.

What Is Tirzepatide?

Tirzepatide is a first-in-class dual receptor agonist — it activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, unlike single-target GLP-1 medications such as semaglutide or liraglutide. This dual mechanism is why tirzepatide has shown greater average weight loss in head-to-head clinical data than GLP-1-only drugs.

Which Medications Contain Tirzepatide?


Mounjaro®

Zepbound®

Approved for

Type 2 diabetes; cardiovascular risk reduction in adults with HFpEF

Chronic weight management; obstructive sleep apnea in adults with obesity

Maintenance doses

5 mg, 10 mg, or 15 mg weekly

5 mg, 10 mg, or 15 mg weekly

Manufacturer

Eli Lilly

Eli Lilly

Both share the identical titration ladder — starting at 2.5 mg weekly and increasing every 4 weeks toward a maximum of 15 mg.

How Tirzepatide Works

  • Activates GIP receptors, which enhances insulin secretion and may improve fat metabolism

  • Activates GLP-1 receptors, slowing gastric emptying and suppressing appetite

  • The combined dual action produces stronger effects on both blood sugar and appetite than single-pathway GLP-1 medications

Mounjaro vs. Zepbound: The Short Version

Same molecule, different approved purpose. Mounjaro is approved for type 2 diabetes and, since a 2025 label update, for reducing cardiovascular risk in adults with heart failure with preserved ejection fraction. Zepbound is approved for chronic weight management and, notably, for obstructive sleep apnea — a distinct approval most people don't know it carries. Full comparison: Mounjaro vs. Zepbound.

Common Side Effects

Nausea, diarrhea, vomiting, constipation, and injection-site reactions are the most frequently reported side effects, most noticeable during dose escalation. Full breakdown: Tirzepatide Side Effects.

Why Tracking Matters During Treatment

Because tirzepatide affects appetite and digestion more strongly than many other GLP-1 medications, tracking your weekly dose, weight trend, appetite, hydration, protein intake, and symptoms gives your care team a clearer picture than relying on memory. DietApp logs all of this in one place.

Frequently Asked Questions

Is tirzepatide the same as Mounjaro?Mounjaro is a brand name for tirzepatide, approved for type 2 diabetes.

Is tirzepatide the same as Zepbound?Zepbound is a brand name for tirzepatide, approved for chronic weight management and obstructive sleep apnea.

Is tirzepatide stronger than semaglutide?Head-to-head trial data has shown tirzepatide producing greater average weight loss than semaglutide, attributed to its dual GLP-1/GIP mechanism — though individual response varies.

Can I switch between Mounjaro and Zepbound?Only under a healthcare provider's guidance.

Explore All GLP-1 Medications on DietApp.com

Liraglutide Family

Semaglutide Family

Tirzepatide Family

Written by Hattie Sykes, Manager at DietApp.com. This article is for general informational purposes only and is not medical advice. Consult your healthcare provider before starting, stopping, or switching any medication.

 
 
 

Comments

bottom of page